doi: 10.1093/eurheartj/ehae563 2 KollerDPathakGAWendtFRTyleeDSLeveyDFOverstreetCet al
469 Importantly, the GLP-1-carotid body pathway may represent a novel therapeutic target for managing cardiovascular metabolism and treating patients with diabetes and hypertension who exhibit heightened sympathetic activity
[ CrossRef ] [ Google scholar ] [ PubMed ] Pickart L, Freedman JH, Loker WJ, Peisach J, Perkins CM, Stenkamp RE, et al
Patients with HF often exhibit reduced circulating levels of SCFAs
Related lab tests: Hemoglobin A1C, Glucose, Comprehensive Metabolic Panel, Kidney Profile, Lipid Panel, Lipase, Amylase, Hepatic Function Panel with GGT, CBC, Ferritin, Iron and TIBC, Vitamin B12, Folate, and Vitamin D
Frequently Asked Questions How long before I see results with GHK-Cu Cream